Search
we the people worked with CoLab, a partnership between The Kids and Minderoo Foundation, to investigatethe needs of local families with children aged 0to8
It is plausible that offspring born to mothers using tobacco during pregnancy may have increased risk of mood disorders (depression and bipolar disorders); however, mixed results have been reported.
An InFocus Research Interview with Kirsten Hancock of the Human Capability Team at The Kids Research Institute Australia on multigenerational disadvantage in Australia.
New ways to deliver more effective, evidenced-informed child development services will be forged through an innovative community partnership in the Central Great Southern.
A new report on families with 0-4 year olds in the Midland area aims to help shape development of the sector and ensure parents are better placed to access support in their efforts to ensure the healthy development of their babies and toddlers.
Philanthropist and early childhood advocate Nicola Forrest has been recognised for her tirelesss commitment to the sector through being awarded an Officer of the Order of Australia.
The first major national study into the cost of providing late intervention services to children and young people has called for smarter and wiser expenditure to ensure children receive vital support services at a much earlier stage.
The nuanced message conveys the foundational importance of child development in the early years but avoids triggering concerns there are no opportunities to intervene at a later age.
Asymptomatic or subclinical SARS-CoV-2 infections are often unreported, which means that confirmed case counts may not accurately reflect underlying epidemic dynamics. Understanding the level of ascertainment (the ratio of confirmed symptomatic cases to the true number of symptomatic individuals) and undetected epidemic progression is crucial to informing COVID-19 response planning, including the introduction and relaxation of control measures.
The monoclonal antibody, palivizumab is licensed for use in high-risk infants to prevent severe illness caused by respiratory syncytial virus (RSV). The level of its use and compliance with current jurisdictional guidelines which were amended in 2010, is unknown.